Application Note: WB: 1:300-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
Calculated MW: 79
Form: Liquid
Buffer (with preservative): 1% BSA, 50% Glycerol, 0.09% Sodium azide.
Concentration: 1 mg/ml (Please refer to the vial label for the specific concentration.)
Background: This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy. [provided by RefSeq, Jul 2008]
Uniprot ID: P10636
Antigen Species: Human
Immunogen: KLH conjugated synthetic phosphopeptide derived from human Tau around the phosphorylation site of Thr231 [VR(p-T)PP]
Purification: Protein A purified
Conjugation: Unconjugated
Full Name: microtubule associated protein tau